Q3 2024 Elevance Health Inc Earnings Call Transcript
Key Points
- Elevance Health Inc (ELV) reported strong revenue growth of over 5% year-over-year, reaching $44.7 billion for the third quarter.
- The company is expanding its individual and family ACA plans in three states, which is expected to drive growth in its health benefits and Carelon segments.
- CarelonRx continues to expand its customer base and recently closed the acquisition of Kroger Specialty Pharmacy, aligning with its strategy to deliver whole health affordably.
- Elevance Health Inc (ELV) is investing in AI-driven solutions to enhance member and provider experiences, reduce costs, and improve operational efficiency.
- The company is confident in its long-term growth strategy, expecting to deliver at least 12% growth in adjusted diluted earnings per share annually over time.
- Elevance Health Inc (ELV) reported adjusted diluted earnings per share of $8.37, which was below expectations due to elevated medical costs in its Medicaid business.
- The company has reduced its full-year outlook for adjusted diluted earnings per share to approximately $33, reflecting challenges in the operating environment.
- Medicaid cost trends are developing worse than expected, with trends running 3 to 5 times historical averages, leading to inadequate rate coverage.
- The percentage of members in Medicare Advantage plans rated four stars or higher is expected to decline due to higher cut points.
- Elevance Health Inc (ELV) is facing a timing disconnect between Medicaid rates and acuity, which is expected to persist through 2025, impacting margins.
Ladies and gentlemen, thank you for standing by and welcome to the Elevance Health third-quarter earnings conference call. (Operator Instructions) As a reminder, today's conference is being recorded.
I would now like to turn the conference over to the company's management. Please go ahead.
Good morning and welcome to Elevance Health third quarter 2024 earnings call. This is Stephen Tanal, Vice President of Investor Relations. And with us this morning on the earnings call are Gail Boudreaux, President and CEO; Mark Kaye, our CFO; Peter Haytaian, President of Carelon; Morgan Kendrick, President of our Commercial Health Benefits Business; and Felicia Norwood, President of our Government Health Benefits Business.
Gail will begin the call with a brief discussion of the quarter and our revised outlook for the year and recent progress against our strategic initiatives. Mark will then discuss our financial results and outlook in greater detail. After our prepared remarks, the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
